Adenosine at Reperfusion. A Conundrum Ready to Be Resolved

Journal of the American College of Cardiology

Volumn 53, Issue 8, 2009, Pages 718-719

  Cohen, Michael V ^a   Downey, James M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

adenosine; drug delivery system; liposome; myocardial infarction

Indexed keywords

ADENOSINE; ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; BAY 606583; LIPOSOME; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANAEROBIC METABOLISM; DRUG DELIVERY SYSTEM; DRUG MECHANISM; EDITORIAL; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HYPOTENSION; ISCHEMIC PRECONDITIONING; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE; ANIMALS; CARDIOTONIC AGENTS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; VASODILATOR AGENTS;

EID: 60049085297     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.11.016     Document Type: Editorial

References (19)

1. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
2. 1 adenosine receptors in rabbit heart. Circulation 84 (1991) 350-356
3. Olafsson B., Forman M.B., Puett D.W., et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 76 (1987) 1135-1145
4. Norton E.D., Jackson E.K., Virmani R., and Forman M.B. Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral blood flow. Am Heart J 122 (1991) 1283-1291
5. Velasco C.E., Turner M., Cobb M.A., Virmani R., and Forman M.B. Myocardial reperfusion injury in the canine model after 40 minutes of ischemia: effect of intracoronary adenosine. Am Heart J 122 (1991) 1561-1570
6. Pitarys II C.J., Virmani R., Vildibill Jr. H.D., Jackson E.K., and Forman M.B. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation 83 (1991) 237-247
7. 2-receptor agonists on myocardial reperfusion injury. Am Heart J 123 (1992) 332-338
8. Goto M., Miura T., Iliodoromitis E.K., et al. Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species. Cardiovasc Res 25 (1991) 943-949
9. Vander Heide R.S., and Reimer K.A. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Cardiovasc Res 31 (1996) 711-718
10. Budde J.M., Velez D.A., Zhao Z.-Q., et al. Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion. Cardiovasc Res 47 (2000) 294-305
11. 2 receptors. J Cardiovasc Pharmacol 38 (2001) 474-481
12. Mahaffey K.W., Puma J.A., Barbagelata N.A., et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction. Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol 34 (1999) 1711-1720
13. Ross A.M., Gibbons R.J., Stone G.W., Kloner R.A., and Alexander R.W. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 45 (2005) 1775-1780
14. Takahama H., Minamino T., Asanuma H., et al. Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats. J Am Coll Cardiol 53 (2009) 709-717
15. 2b-dependent signaling during early reperfusion. J Mol Cell Cardiol 43 (2007) 262-271
16. 2b receptor cascade. Cardiovasc Res 70 (2006) 308-314
17. Kin H., Zatta A.J., Lofye M.T., et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 67 (2005) 124-133
18. 2A receptor agonist, in reperfused canine myocardium. Am J Physiol 288 (2005) H1851-H1858
19. Tissier R., Cohen M.V., and Downey J.M. Protecting the acutely ischemic myocardium beyond reperfusion therapies: are we any closer to realizing the dream of infarct size elimination?. Arch Mal Coeur Vaiss 100 (2007) 794-802